ARISTEA THERAPEUTICS
Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.The company's therapies include developing drugs, enabling inflammatory diseases patients to address their unmet medical needs.
ARISTEA THERAPEUTICS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2018-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.aristeatx.com
Total Employee:
1+
Status:
Active
Contact:
858-987-4064
Email Addresses:
[email protected]
Total Funding:
117.62 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Amazon SSL By Default Microsoft Exchange Online Office 365 Mail GoDaddy DNS AWS Global Accelerator
Similar Organizations
Alchemab Therapeutics
Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Engrail Therapeutics
Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals is developing therapies for inflammatory and autoimmune conditions.
Memo Therapeutics
Memo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis.
Skye Bioscience
Skye Bioscience is a biopharmaceutical company focused on the discovery, development, and the commercialization.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Sonoma BioTherapeutics
Sonoma BioTherapeutics develops adoptive Treg therapies cell for autoimmune.
Vico Therapeutics
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Arena Pharmaceuticals
Arena Pharmaceuticals investment in Series B - Aristea Therapeutics
Fidelity
Fidelity investment in Series B - Aristea Therapeutics
Novo Holdings
Novo Holdings investment in Series B - Aristea Therapeutics
Tekla Capital Management
Tekla Capital Management investment in Series B - Aristea Therapeutics
Novo Holdings
Novo Holdings investment in Series A - Aristea Therapeutics
Official Site Inspections
http://www.aristeatx.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Aristea Therapeutics"
Aristea Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number 858-987-4064 Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.The company's therapies include developing drugs, enabling …See details»
Aristea Therapeutics, Inc. Company Profile | San Diego, CA ...
Find company research, competitor information, contact details & financial data for Aristea Therapeutics, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Aristea Therapeutics - VentureRadar
Similar Companies: Immunic Therapeutics Germany Publicly Traded Immunic is a specialist in selective oral drugs in immunology and focused on developing novel oral therapies with best …See details»
Aristea Therapeutics Company Profile - Office Locations ... - Craft
Mar 28, 2022 Aristea Therapeutics has 5 employees at their 1 location and $78 m in total funding,. See insights on Aristea Therapeutics including office locations, competitors, revenue, …See details»
Aristea Therapeutics Company Profile 2024: Valuation, Funding ...
Aristea Therapeutics General Information Description. Operator of a drug development company intended to treat serious inflammatory diseases. The company develops new medicines …See details»
Aristea Therapeutics Launches with Phase 2 Drug Candidate and …
Dec 18, 2018 "We look forward to building out the organization and advancing RIST4721 through Phase 2." ... To learn more, please visit www.aristeatx.com. Contact: Amy Conrad …See details»
Aristea Completes $63 Million Series B Financing to Accelerate …
Jul 27, 2021 To learn more, please visit www.aristeatx.com and follow us on social media @Aristeatx. For media inquiries contact: David Schull or Ignacio Guerrero-Ros, Ph.D. Russo …See details»
Aristea Therapeutics Announces Key Leadership Appointments
Jan 13, 2022 To learn more, please visit www.aristeatx.com and follow us on social media @Aristeatx. For media inquiries contact: David Schull or Ignacio Guerrero-Ros, Ph.D. Russo …See details»
Aristea Therapeutics Announces Dosing of First Patient in Phase 2b ...
Mar 28, 2022 To learn more, please visit www.aristeatx.com and follow us on Twitter (@Aristeatx) and LinkedIn (Aristea Therapeutics). For media inquiries contact: David Schull or …See details»
Aristea Therapeutics to Present at the 2nd Annual LifeSci Partners ...
Jul 16, 2021 To learn more, please visit www.aristeatx.com and follow us on social media @Aristeatx. For media inquiries contact: David Schull or Ignacio Guerrero-Ros Russo Partners …See details»
Aristea Therapeutics Closes $63M Series B Financing - FinSMEs
Jul 27, 2021 and follow us on social media @Aristeatx. For media inquiries contact: David Schull or Ignacio Guerrero-Ros, Ph.D. Russo Partners 858-717-2310 646-942-5604 [email protected],See details»
aristeatx.com
Aristeatx.comSee details»
Aristea Therapeutics Announces Dosing of First Patient in
Mar 28, 2022 To learn more, please visit www.aristeatx.com and follow us on Twitter (@Aristeatx) and LinkedIn (Aristea Therapeutics). For media inquiries contact: David Schull or …See details»
Aristea Therapeutics Announces Key Leadership Appointments to …
Jan 13, 2022 To learn more, please visit www.aristeatx.com and follow us on social media @Aristeatx. For media inquiries contact: David Schull or Ignacio Guerrero-Ros, Ph.D. Russo …See details»
Arena Pharmaceuticals and Aristea Therapeutics Establish …
Jul 27, 2021 To learn more, please visit www.aristeatx.com and follow us on social media @Aristeatx Forward-Looking Statements Certain statements in this press release are forward …See details»
Aristea Therapeutics - Facebook
Aristea Therapeutics. 9 likes. Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage drug development company developing novel therapies to treat...See details»
Aristea Appoints Justin Thacker as Chief Financial Officer - PR …
Aug 23, 2021 To learn more, please visit www.aristeatx.com and follow us on social media @Aristeatx. For media inquiries contact: David Schull or Ignacio Guerrero-Ros, Ph.D. Russo …See details»
Areteia Therapeutics - Home
Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral …See details»
Aristea Therapeutics Strengthens its Board of Directors with the ...
Aug 24, 2022 Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage immunology focused drug development company developing novel therapies to treat serious inflammatory diseases.See details»
Aristea Therapeutics to Present at Biotech Showcase 2022 and H.C ...
Jan 6, 2022 To learn more, please visit www.aristeatx.com and follow us on social media @Aristeatx. For media inquiries contact: David Schull or Ignacio Guerrero-Ros, Ph.D. Russo …See details»